How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

White Papers
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat
Webcast
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic
Webcast
This short webcast will give you a brief overview of the current ISM® Report On Business, share details surrounding the development of the new
Webcast
Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the value of UDI adoption with Mike…
Webcast
Data visualization can help translate dashboards, benchmarking and metrics lines, and lines of supply chain data into actionable insight.